Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

被引：0
|
作者：
Axel Heidenreich
Silke Gillessen
Daniel Heinrich
Daniel Keizman
Joe M. O’Sullivan
Joan Carles
Manfred Wirth
Kurt Miller
John Reeves
Monica Seger
Sten Nilsson
Fred Saad
机构：
[1] University Hospital Cologne,Department of Urology
[2] Division of Cancer Sciences,Department of Oncology
[3] University of Manchester and the Christie,Department of Medical Oncology
[4] Medical Oncology and Haematology,Department of Urology
[5] Kantonsspital St Gallen,Department of Urology
[6] University of Bern,Department of Oncology
[7] Akershus University Hospital,Department of Urology
[8] Genitourinary Oncology Service,undefined
[9] Institute of Oncology,undefined
[10] Meir Medical Center,undefined
[11] Department of Clinical Oncology,undefined
[12] The Centre for Cancer Research and Cell Biology,undefined
[13] Queen’s University Belfast and the Northern Ireland Cancer Centre,undefined
[14] Vall d’Hebron University Hospital,undefined
[15] Vall d’Hebron Institute of Oncology,undefined
[16] University Hospital Carl-Gustav Carus,undefined
[17] Charité University Medicine Berlin,undefined
[18] Pharmaceutical Division of Bayer,undefined
[19] Karolinska University Hospital,undefined
[20] Centre Hospitalier de l’Université de Montréal (CHUM),undefined
来源：
BMC Cancer | / 19卷
关键词：
Radium-223; mCRPC, asymptomatic; Symptomatic; Bone metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] RADIUM-223 RE-TREATMENT: EXPERIENCE FROM AN INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER AND BONE METASTASES
    Nordquist, Luke
    Keizman, Daniel
    Saba, Kfar
    Mariados, Neil
    Mendez Vidal, Maria Jose
    Thellenberg-Karlsson, Camilla
    Peer, Avivit
    Procopio, Giuseppe
    Frank, Stephen J.
    Pulkkanen, Kalevi
    Severi, Stefano
    Trigo Perez, Jose Manuel
    Schwarzenberger, Paul
    Li, Rui
    Sartor, Oliver
    JOURNAL OF UROLOGY, 2016, 195 (04): : E678 - E679
  • [42] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [43] Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients.
    Saad, Fred
    Carles, Joan
    Gillessen, Silke
    Heinrich, Daniel
    Gratt, Jeremy
    Miller, Kurt
    Nilsson, Sten
    O'Sullivan, Joe
    Tucci, Marcello
    Wirth, Manfred
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
    van der Doelen, Maarten J.
    Stockhaus, Agnes
    Ma, Yuanjun
    Mehra, Niven
    Yachnin, Jeffrey
    Gerritsen, Winald R.
    Nilsson, Sten
    van Oort, Inge M.
    Ullen, Anders
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (10) : 3325 - 3334
  • [45] Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
    Maarten J. van der Doelen
    Agnes Stockhaus
    Yuanjun Ma
    Niven Mehra
    Jeffrey Yachnin
    Winald R. Gerritsen
    Sten Nilsson
    Inge M. van Oort
    Anders Ullén
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3325 - 3334
  • [46] Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer
    Unda-Urzaiz, M.
    Sousa-Campo, R.
    Rodriguez-Antolin, A.
    Silva-Marins, C.
    Juarez-Soto, A.
    Minana-Lopez, B.
    Figueiredo-de Castro, A.
    Cozar-Olmos, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (04): : 227 - 237
  • [47] Efficacy of radium-223 dichloride in castration-resistant metastatic prostate cancer
    Sobrevilla Calvo, Pedro de Jesus
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 26 - 27
  • [48] Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 764 - 766
  • [49] Radium-223 chloride: Radiation safety, tolerability, and survival gain in patients with castration-resistant prostate cancer (CRPC) and bone metastases
    Lewington, Valerie
    Lamey, Roy
    Staudacher, Karin
    Vogelzang, Nicholas
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [50] Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
    Cha, Tai-Lung
    Wu, Tony Tong-Lin
    Vogelzang, Nicholas John
    Huang, Chao-Yuan
    Huang, Shu-Pin
    Lin, Chia-Chi
    Ou, Yen-Chuan
    Pang, See-Tong
    Shen, Daniel Heung-Yuan
    Wu, Wen-Jeng
    Chang, Wayne Yen-Hwa
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (11) : 825 - 836
12345